H.C. Wainwright Maintains Anavex Life Sciences(AVXL.US) With Buy Rating, Maintains Target Price $42
Promising Long-Term Benefits and Market Potential of Blarcamesine in Alzheimer's Treatment Justify Buy Rating for Anavex Life Sciences
Anavex Life Sciences Shares Rise After Positive Trial Results for Alzheimer's Treatment
Anavex Life Sciences Reveals Peer-reviewed Publication Of Oral Blarcamesine Phase IIb/III Data In Journal Of Prevention Of Alzheimer's Disease
Express News | Anavex Life Sciences Announces Peer-Reviewed Publication of Oral Blarcamesine Phase Iib/III Data in the Journal of Prevention of Alzheimer’s Disease
Anavex Life Sciences Announces Peer-Reviewed Publication of Oral Blarcamesine Phase IIb/III Data in The Journal of Prevention of Alzheimer's Disease
Rhiox : getting close
Rhiox : i usually load up when its in the mid 8.'s. Have done pretty good with that enrty point many times over.